Expression of stabilin-1 in M2 macrophages in human granulomatous disease and melanocytic lesions

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 4, 2014, Pages 1625-1634

  Schönhaar, Kathrin ^a   Schledzewski, Kai ^a   Michel, Julia ^a   Dollt, Claudia ^a   Gkaniatsou, Cleopatra ^b   Géraud, Cyrill ^a   Kzhyshkowska, Julia ^a   Goerdt, Sergij ^a   Schmieder, Astrid ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Internal Medicine City Hospital Baden Baden   (Germany)

Author keywords

M2 macrophages; Marker molecules; Melanocytic nevus; Melanoma; Tumor associated macrophages; Tumor classification; Xanthogranuloma

Indexed keywords

HOMING RECEPTOR; NERVE CELL ADHESION MOLECULE; STAB1 PROTEIN, HUMAN; STAB1 PROTEIN, MOUSE;

ADULT; AGED; ANIMAL; DEFICIENCY; DISEASE MODEL; FEMALE; GENETICS; HISTIOCYTOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; JUVENILE XANTHOGRANULOMA; KNOCKOUT MOUSE; LYMPH NODE; MACROPHAGE; MALE; MELANOMA; METABOLISM; MIDDLE AGED; MOUSE; NECROBIOTIC XANTHOGRANULOMA; PATHOLOGY; PIGMENTED NEVUS; RETROSPECTIVE STUDY; SKIN TUMOR; VERY ELDERLY; XENOGRAFT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL ADHESION MOLECULES, NEURONAL; DISEASE MODELS, ANIMAL; FEMALE; HETEROGRAFTS; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MACROPHAGES; MALE; MELANOMA; MICE; MICE, KNOCKOUT; MIDDLE AGED; NECROBIOTIC XANTHOGRANULOMA; NEVUS, PIGMENTED; RECEPTORS, LYMPHOCYTE HOMING; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; XANTHOGRANULOMA, JUVENILE;

EID: 84899558862     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Goerdt S, Walsh LJ, Murphy GF and Pober JS. Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. J Cell Biol 1991; 113: 1425-1437.
2. Goerdt S and Orfanos CE. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999; 10: 137-142.
3. Goerdt S, Kolde G, Bonsmann G, Hamann K, Czarnetzki B, Andreesen R, Luger T and Sorg C. Immunohistochemical comparison of cutaneous histiocytoses and related skin disorders: diagnostic and histogenetic relevance of MS-1 high molecular weight protein expression. J Pathol 1993; 170: 421-427.
4. Kzhyshkowska J, Gratchev A, Schmuttermaier C, Brundiers H, Krusell L, Mamidi S, Zhang J, Workman G, Sage EH, Anderle C, Sedlmayr P and Goerdt S. Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis. J Immunol 2008; 180: 3028-3037.
5. Kzhyshkowska J, Workman G, Cardo-Vila M, Arap W, Pasqualini R, Gratchev A, Krusell L, Goerdt S and Sage EH. Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J Immunol 2006; 176: 5825-5832.
6. Li R, Oteiza A, Sorensen KK, McCourt P, Olsen R, Smedsrod B and Svistounov D. Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins. Am J Physiol Gastrointest Liver Physiol 2011; 300: G71-81.
7. Pempe EH, Xu Y, Gopalakrishnan S, Liu J and Harris EN. Probing structural selectivity of synthetic heparin binding to Stabilin protein receptors. J Biol Chem 2012; 287: 20774-20783.
8. Kzhyshkowska J. Multifunctional receptor stabilin-1 in homeostasis and disease. ScientificWorldJournal 2010; 10: 2039-2053.
9. Schledzewski K, Geraud C, Arnold B, Wang S, Grone HJ, Kempf T, Wollert KC, Straub BK, Schirmacher P, Demory A, Schonhaber H, Gratchev A, Dietz L, Thierse HJ, Kzhyshkowska J and Goerdt S. Deficiency of liver sinusoidal scavenger receptors stabilin-1 and-2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. J Clin Invest 2011; 121: 703-714.
10. Politz O, Gratchev A, McCourt PA, Schledzewski K, Guillot P, Johansson S, Svineng G, Franke P, Kannicht C, Kzhyshkowska J, Longati P, Velten FW, Johansson S and Goerdt S. Stabilin-1 and-2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002; 362: 155-164.
11. Martens JH, Kzhyshkowska J, Falkowski-Hansen M, Schledzewski K, Gratchev A, Mansmann U, Schmuttermaier C, Dippel E, Koenen W, Riedel F, Sankala M, Tryggvason K, Kobzik L, Moldenhauer G, Arnold B and Goerdt S. Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J Pathol 2006; 208: 574-589.
12. Schledzewski K, Falkowski M, Moldenhauer G, Metharom P, Kzhyshkowska J, Ganss R, Demory A, Falkowska-Hansen B, Kurzen H, Ugurel S, Geginat G, Arnold B and Goerdt S. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol 2006; 209: 67-77.
13. Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstrom J, Salmi M, Ristamaki R and Jalkanen S. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Cancer 2012; 131: 864-73.
14. Palani S, Maksimow M, Miiluniemi M, Auvinen K, Jalkanen S and Salmi M. Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages. Eur J Immunol 2011; 41: 2052-63.
15. Schmieder A, Schledzewski K, Michel J, Schonhaar K, Morias Y, Bosschaerts T, Van den Bossche J, Dorny P, Sauer A, Sticht C, Geraud C, Waibler Z, Beschin A and Goerdt S. The CD20 homolog Ms4a8a integrates pro-and anti-inflammatory signals in novel M2-like macrophages and is expressed in parasite infection. Eur J Immunol 2010; 42: 2971-2982.
16. David C, Nance JP, Hubbard J, Hsu M, Binder D and Wilson EH. Stabilin-1 expression in tumor associated macrophages. Brain Res 2012; 1481: 71-78.
17. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686.
18. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
19. Murray PJ and Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11: 723-737.
20. Weaver LK, Pioli PA, Wardwell K, Vogel SN and Guyre PM. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors. J Leukoc Biol 2007; 81: 663-671.
21. Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstrom J, Salmi M, Ristamaki R and Jalkanen S. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Int J Cancer 2012; 131: 864-873.
22. Goerdt S and Sorg C. Endothelial heterogeneity and the acquired immunodeficiency syndrome: a paradigm for the pathogenesis of vascular disorders. Clin Investig 1992; 70: 89-98.
23. Matsuura F, Yamashita S, Hirano K, Ishigami M, Hiraoka H, Tamura R, Nakagawa T, Nishida M, Sakai N, Nakamura T, Nozaki S, Funahashi T, Matsumoto C, Higashiyama M, Yoshikawa K and Matsuzawa Y. Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia-a possible pathogenesis of necrobiotic xanthogranuloma. Atherosclerosis 1999; 142: 355-365.
24. Adamson H. Society intelligence: The Dermatological Society of London. Br J Dermatol 1905; 17: 222.
25. Gartmann H and Tritsch H. [Nevoxanthoendothelioma with small and large nodules. Report on 13 cases]. Arch Klin Exp Dermatol 1963; 215: 409-421.
26. Gianotti F, Caputo R and Ermacora E. [Singular "infantile histiocytosis with cells with intracytoplasmic vermiform particles"]. Bull Soc Fr Dermatol Syphiligr 1971; 78: 232-233.
27. Montgomery HOA. Xanthomatosis: correlation of clinical, histopathologic and chemical studies of cutaneous xanthoma. Arch Derm Syphilol 1938; 37: 373-402.
28. Winkelmann RK. Cutaneous syndromes of non-X histiocytosis. A review of the macrophage-histiocyte diseases of the skin. Arch Dermatol 1981; 117: 667-672.
29. Taunton OD, Yeshurun D and Jarratt M. Progressive nodular histiocytoma. Arch Dermatol 1978; 114: 1505-1508.
30. Zelger BG, Zelger B, Steiner H and Mikuz G. Solitary giant xanthogranuloma and benign cephalic histiocytosis-variants of juvenile xanthogranuloma. Br J Dermatol 1995; 133: 598-604.